APA (7th ed.) Citation

ML, R., JG, K., LJ, S., GI, R., SG, E., MA, V., . . . DD, v. H. (2001). Phase I dose-finding and pharmacokinetic trial of irinotecan (CPT-11) administered every two weeks. Annals of oncology : official journal of the European Society for Medical Oncology, 12(11), 1631. https://doi.org/10.1023/a:1013157727506

Chicago Style (17th ed.) Citation

ML, Rothenberg, et al. "Phase I Dose-finding and Pharmacokinetic Trial of Irinotecan (CPT-11) Administered Every Two Weeks." Annals of Oncology : Official Journal of the European Society for Medical Oncology 12, no. 11 (2001): 1631. https://doi.org/10.1023/a:1013157727506.

MLA (9th ed.) Citation

ML, Rothenberg, et al. "Phase I Dose-finding and Pharmacokinetic Trial of Irinotecan (CPT-11) Administered Every Two Weeks." Annals of Oncology : Official Journal of the European Society for Medical Oncology, vol. 12, no. 11, 2001, p. 1631, https://doi.org/10.1023/a:1013157727506.